House Panel Raises Alarms Over Drug Price Increases

Law360, New York (December 8, 2009, 3:30 PM EST) -- Members of the U.S. House of Representatives on Tuesday said stronger price controls should be included in health care reform legislation to stem the rising cost of prescription drugs, pointing to a new AARP study that claims brand-name drug costs went up more than 9 percent in 2009.

While the House already has passed its version of the health care bill, Energy and Commerce chairman Henry Waxman, D-Calif., said during a health subcommittee hearing that the rising drug prices were “exhibit A” for why new taxpayer...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.